Atlantic Street Capital announced that it will form Advancing Eyecare Holdings with a partnership between Marco Ophthalmic and Atlantic’s portfolio company, Lombart Instrument.The transaction is expected to be completed in the first quarter of 2019 and…
Author: Healio ophthalmology
VIDEO: What’s new in IOL calculations
NEW YORK — From OSN New York 2018, Mitchell P. Weikert, MD, associate professor at the Cullen Eye Institute, Baylor College of Medicine, gives his presentation on the latest in how to perform IOL calculations for cataract surgery.
Price hikes on older, brand-name drugs share blame for surging drug costs
The pharmaceutical industry, in recent years, has been marked by a cycle of outrage from patient groups, insurers and politicians each time a particularly expensive new drug hits the market. The considerable ticket price attached to blockbuster newcome…
Ocular Therapeutix submits supplemental NDA for Dextenza
A supplemental new drug application for Dextenza has been submitted to the FDA to expand its indication to include the treatment of ocular inflammation after ophthalmic surgery, Ocular Therapeutix announced in a press release.Dextenza (dexamethasone op…
VIDEO: State of the art of intracameral antibiotics and steroids
NEW YORK — From OSN New York 2018, Keith Walter, MD, professor of ophthalmology and director of refractive surgery at Wake Forest University, gives his presentation on the state of the art of intracameral antibiotics and steroids for “drop-free” catara…
Allergan reports continued focus on eye care business
Allergan’s commitment to its eye care business includes advancing new products for both the front and back of the eye, CEO Brent Saunders said at the 37th annual J.P. Morgan Healthcare Conference in San Francisco.The company’s business plan included a …
VIDEO: Software and apps to improve today’s cataract surgeon
NEW YORK — From OSN New York 2018, Tal Raviv, MD, founder and medical director of Eye Center of New York, gives his presentation on different software and apps that will help cataract surgeons improve their practice.
Optometry must follow neurology’s standard of care in retinal artery obstruction
Neurologists consider an acute retinal artery obstruction a true medical emergency and classify it as a stroke.Scott C. Richards, MD, suggests optometrists implement a “major shift” in the referral pattern for retinal artery obstructions by taking a pa…
Large data set correlates cholesterol levels with AMD
HDL cholesterol and triglycerides have, respectively, a positive and negative association with increased risk for age-related macular degeneration, particularly in the early stages, according to a study.Researchers analyzed the correlation between circ…
Spark leverages Luxturna success to move gene therapies forward
Spark Therapeutics’ success with Luxturna is spurring the company to develop more gene therapies for other genetic diseases, Jeffrey D. Marrazzo, the company’s co-founder and CEO, said at the 37th annual J.P. Morgan Healthcare Conference in San Francis…
VIDEO: Leber hereditary optic neuropathy gene therapy shows positive results
CHICAGO — Mark L. Moster, MD, of Wills Eye Hospital, discusses results of the REVERSE clinical trial, which is evaluating the efficacy of GS010 (GenSight Biologics) to treat Leber hereditary optic neuropathy, at the American Academy of Ophthalmology me…
Ciliary neurotrophic factor may benefit patients with macular telangiectasia type 2
Intravitreal sustained delivery of human ciliary neurotrophic factor showed efficacy in slowing the progression of retinal degeneration in patients with macular telangiectasia type 2, a condition with no known effective therapy.Ciliary neurotrophic fac…
Takeda completes Shire acquisition
Takeda Pharmaceutical has completed its acquisition of Shire, 8 months after the deal was announced, according to a press release.The deal was approved by 89.1% of Takeda’s shareholders and 99.8% of Shire’s shareholders, the release said.“We are deligh…
ProQR to begin phase 2/3 trial of treatment for Leber’s congenital amaurosis 10
ProQR Therapeutics and the FDA have reached an agreement regarding the design of the phase 2/3 ILLUMINATE trial of the company’s RNA-based oligonucleotide treatment candidate for Leber’s congenital amaurosis 10, according to a press release.The double-…
Direct-to-consumer medical ad spending rises $7.5 billion over 10 years
Money spent on medical marketing greatly increased from 1997 through 2016, carried largely by a significant surge in direct-to-consumer advertising, which rose from $2.1 billion to $9.6 billion during that time, according to data published in JAMA.“Hea…
BioTime, Orbit Biomedical to collaborate on OpRegen subretinal delivery for dry AMD
BioTime has entered into a research and option agreement with Orbit Biomedical regarding technology to deliver OpRegen to treat dry age-related macular degeneration, according to a press release.Under the terms of the exclusive 12-month agreement, the …
Woman presents with decreased night vision
A 56-year-old Caucasian woman was referred from an outside office to the Neuro-ophthalmology service at the New England Eye Center for evaluation of decreased night vision. Her symptoms started about 2 months before her presentation, when she noticed s…
Well-trained pediatric optometrists can help fill access gaps
Incorporating well-trained pediatric optometrists into pediatric ophthalmology practices has helped expand primary pediatric eye care services to children, often closing gaps in access to this often routine but nonetheless important service.An American…
Swept-source OCT: A new frontier in study and management of choroidal disorders
Swept-source OCT with the Topcon DRI Triton system provides high-resolution imaging of the choroid, allowing visualization of previously unknown disease manifestations, according to one researcher. The combination of high speed and longer wavelength en…
Vital dyes necessary for vitreomacular surgery but may have risks
Vital dyes are used by vitreoretinal specialists to visualize transparent preretinal tissues, to enhance identification and to remove transparent anatomical layers during vitreoretinal surgery, but the dyes can result in irreversible acute toxicity in …